Merck To Stop Phase 3 HYPERION Study Early
(RTTNews) - Merck & Co Inc. (MRK), Thursday said it has decided to stop the Phase 3 HYPERION study evaluating Winrevair in pulmonary arterial hypertension (PAH). The HYPERION study is designed to ...
Merck to stop Phase 3 HYPERION trial
Merck (MRK) announced the Phase 3 HYPERION study evaluating WINREVAIR versus placebo in recently diagnosed adults with pulmonary arterial ...
Weight-Loss Surgery Protects Liver Health
THURSDAY, Jan. 30, 2025 (HealthDay News) -- Weight-loss surgery can protect the liver health of patients with obesity and ...
Cholesterol Changes in Seniors Linked to Brain Health
However, research into the impact of cholesterol on brain health in seniors has yielded mixed results. Some studies have said ...
The subtle trick supermarkets use to get you to spend more
Drowning out the usual squeak of trolley wheels and customers mumbling through their shopping list is Santana’s smooth ...